According to a new study published in this week, the surviving patients following prostate cancer, androgen deprivation therapy host (ADT), the treatment commonly used to block the release of male hormones, are at higher risk of developing chronic diseases.
A study on the analysis of pharmaceutical records about 3,700 survivors of prostate cancer from 2003 to 2014, researchers from the University of South Australia (UniSA) have studied the development of chronic diseases over time.
Data show that survivors of prostate cancer treated with the ADT, more likely to develop cardiovascular disease , depression, diabetes, gastric acid disorders, hyperlipidemia (high blood cholesterol), osteoporosis and inflammatory / pain conditions.
Dr. Ng Hua Shin, who led the study, said previous studies have shown long-term adverse effects of ADT, but this is the first study to explore the development of multiple chronic diseases in Australian conditions. These findings indicate the need for better coordinated assistance to victims of cancer.
"These data will help us to develop an approach based on the needs, to ensure the optimal use of health services, which effectively eliminates multiple chronic conditions to increase the number of cancer survivors in Australia," - says Dr. Vitry.
Prostate cancer - the most common cancer diagnosed in Australian men. In 2017 in Australia there were more than 200,000 men living with prostate cancer. Of these, 80% are long-term survivors, but many of them will die from other causes, mostly chronic conditions.
In Australia, there are no hard numbers, but in a report published in the UK, shows that hospital costs for survivors of prostate cancer with concomitant diseases accounted for 12 000 pounds compared to 2800 pounds for the survivors without chronic health conditions.
In the journal "Prostate cancer" and "Prostatic disease" published an article "The development of comorbidities in men with prostate cancer who were treated with androgen deprivation therapy: a population-based cohort study in Australia."